CX3CR1 and amyotrophic lateral sclerosis: Moreover, there is a lack of consensus regarding the impact of fractalkine isoforms on pathological progression, and comprehensive insights into the significance of CX3CL1 and CX3CR1 in ALS are particularly scarce [43].